ILS Acquires Beckman Coulter Genomics Facility, Creates ILS Genomics | GenomeWeb

NEW YORK (GenomeWeb News) – ILS announced on Friday it has acquired the Morrisville, N.C. site of Beckman Coulter Genomics and formed ILS Genomics.

ILS Genomics provides services in genotyping and gene expression, as well as biologics product safety testing. Sam Tetlow, chief business officer for ILS, was named general manager of ILS Genomics.

The company said that it has capabilities in key platforms for gene expression profiling, including Affymetrix, Illumina, Agilent, Sequenom, and Life Technologies business Applied Biosystems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.